Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
Collongues N, Durand-Dubief F, Lebrun-Frenay C, Audoin B, Ayrignac X, Bensa C, Bigaut K, Bourre B, Carra-Dallière C, Ciron J, Defer G, Kwiatkowski A, Leray E, Maillart E, Marignier R, Mathey G, Morel N, Thouvenot E, Zéphir H, Boucher J, Boutière C, Branger P, Da Silva A, Demortière S, Guillaume M, Hebant B, Januel E, Kerbrat A, Manchon E, Moisset X, Montcuquet A, Pierret C, Pique J, Poupart J, Prunis C, Roux T, Schmitt P, Androdias G, Cohen M. Collongues N, et al. Among authors: da silva a. Mult Scler. 2024 Jun;30(7):899-924. doi: 10.1177/13524585231223880. Epub 2024 Feb 15. Mult Scler. 2024. PMID: 38357870 Review.
Does COVID-19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital.
Quilan F, Lequesne J, Cherifi F, Bastien E, Morel A, Delcambre C, Da Silva A, Grellard JM, Leconte A, Faveyrial A, Clarisse B, Joly F. Quilan F, et al. Among authors: da silva a. Cancer Med. 2023 Sep;12(17):17603-17612. doi: 10.1002/cam4.6378. Epub 2023 Jul 26. Cancer Med. 2023. PMID: 37492987 Free PMC article.
Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors.
Rottier P, Emile G, Johnson A, Levy C, Allouache D, Hrab I, Segura C, Morel A, Villemin M, Dubot-Poitelon C, Boismoreau L, Cherifi F, Lequesne J, Da Silva A. Rottier P, et al. Among authors: da silva a. Front Oncol. 2023 Jan 19;12:1105587. doi: 10.3389/fonc.2022.1105587. eCollection 2022. Front Oncol. 2023. PMID: 36741710 Free PMC article.
HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.
Cherifi F, Da Silva A, Johnson A, Blanc-Fournier C, Abramovici O, Broyelle A, Levy C, Allouache D, Hrab I, Segura C, Morel A, Villemin M, Boscher C, Dubot-Poitelon C, Rottier P, Lequesne J, Emile G. Cherifi F, et al. Among authors: da silva a. BMC Cancer. 2022 Oct 20;22(1):1081. doi: 10.1186/s12885-022-10163-9. BMC Cancer. 2022. PMID: 36266623 Free PMC article.
Abemaciclib-induced reversible grade 4 nephrotoxicity.
Da Silva A, Chretien B, Alexandre J, Emile G. Da Silva A, et al. Breast J. 2020 Nov;26(11):2329-2330. doi: 10.1111/tbj.13980. Epub 2020 Jul 19. Breast J. 2020. PMID: 33098594 No abstract available.
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization's database.
Prevost R, Chretien B, Minoc EM, Dolladille C, Da-Silva A, Nehme A, Joly F, Lelong-Boulouard V, Bastien E. Prevost R, et al. Among authors: da silva a. Front Pharmacol. 2023 Oct 20;14:1278682. doi: 10.3389/fphar.2023.1278682. eCollection 2023. Front Pharmacol. 2023. PMID: 37927591 Free PMC article.
5,342 results